HORSHAM, Pa., Feb. 23, 2017 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release fiscal year ended December 31, 2016 financial results on Thursday, March 9, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Frank J. McCaney, and Chief Financial Officer, Christina Allgeier, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress and answer questions.
Conference Call Details:
| Date: | Thursday, March 9, 2017 |
| Time: | 4:30 pm Eastern Time |
| Toll Free: | 800-327-5138 |
| International: | 719-325-2250 |
| Passcode: | 1973486 |
| Webcast: | www.strataskinsciences.com |
| Replays, available through March 23, 2017 | |
| Toll Free: | 844-512-2921 |
| International: | 412-317-6671 |
| Replay PIN: | 1973486 |
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused in the dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; and the MelaFind System used to assist in the identification and management of melanoma skin cancer.
Investor Contacts: Christina L. Allgeier STRATA Skin Sciences, Inc. 215-619-3267 callgeier@strataskin.com Bob Yedid LifeSci Advisors, LLC 646-597-6989 Bob@LifeSciAdvisors.com
